G. G. Schwartz Et Al. , "Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome," NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.22, pp.2097-2107, 2018
Schwartz, G. G. Et Al. 2018. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.22 , 2097-2107.
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., ... Edelberg, J. M.(2018). Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.22, 2097-2107.
Schwartz, G. Et Al. "Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome," NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.22, 2097-2107, 2018
Schwartz, G. G. Et Al. "Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome." NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.22, pp.2097-2107, 2018
Schwartz, G. G. Et Al. (2018) . "Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome." NEW ENGLAND JOURNAL OF MEDICINE , vol.379, no.22, pp.2097-2107.
@article{article, author={G. G. Schwartz Et Al. }, title={Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2018, pages={2097-2107} }